Striving for Consensus: Current and Future Management of Non-Small Cell Lung Cancer with an EGFR Mutation
About this episode
Dr Pasi Jänne from the Dana-Farber Cancer Institute in Boston, Massachusetts, Prof Tom John from the Peter MacCallum Cancer Centre in Melbourne, Australia, Dr Zofia Piotrowska from Massachusetts General Hospital in Boston, Massachusetts, and Dr Alexander Spira from the Virginia Cancer Specialists Research Program in Fairfax, discuss recent updates on available and emerging treatment strategies for non-small cell lung cancer with an EGFR mutation.
Get every episode summarized
Each time Lung Cancer Update publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Lung Cancer Update
Extensive-Stage Small Cell Lung Cancer — Current Patterns of Care with First-Lin...
Lung Cancer Update
Extensive-Stage Small Cell Lung Cancer — What Clinicians Want to Know About Firs...
Lung Cancer Update
Lung Cancer — Proceedings from a Symposium Held in Partnership with the American...
Lung Cancer Update
HER2-Altered Non-Small Cell Lung Cancer — An Interview with Dr John V Heymach
Lung Cancer Update